Liqtech International IncLIQT

LiqTech International Inc is a micro-cap filtration outfit trying to sell ceramic membrane systems into industries that would rather not spend money on clean water. The company’s Q1 2026 10-Q shows total assets of $24.9m, liabilities of $17.4m, and shareholders’ equity of $7.6m, all while burning $1.9m of operating cash and posting a net loss of $2.7m for the quarter. Cash at quarter-end stood at a lean $2.7m, barely enough to keep the lights on at its silicon-carbide membrane plant in Ballerup, Denmark, let alone fund the next growth push. (source: LIQT 10-Q, 31 March 2026)

On the product side, LiqTech’s promotional pages trumpet ‘industrial water treatment systems for the most extreme conditions,’ complete with hero images of gleaming ceramic filters and cross-flow illustrations worthy of a textbook. The reality is that LiqTech’s filters are real: silicon-carbide membranes designed to resist fouling in harsh wastewater streams. But the company’s ability to monetise that technology is another matter entirely. Its inventory balance rose by $173k in Q1 to $6.5m, a stack of unsold modules that may need markdowns if customers aren’t biting. (source: LiqTech Industrial Water Treatment Systems, https://www.liqtech.com/water-systems/industrial-wastewater/)

LiqTech’s latest SEC filings read like a season of missed milestones. The 24 July 8-K offers zero financial detail on the ‘definitive agreement’ it claims to have signed, while the 5 June 424B4 shelf registration grants the board permission to issue up to $25m of new shares-dilution insurance against further cash burn. Shareholder dilution is already baked into the structure: a 13D/A filed on 9 June disclosed an activist’s 6.1% stake, followed by a 13G on 17 June showing a passive holder at 5.7%, a quiet accumulation that does little to calm nerves over who, exactly, is stepping up to fund the next chapter. (source: LIQT 8-K 2026-07-24, https://www.sec.gov/Archives/edgar/data/1307579/000143774926024425/liqt20260724_8k.htm; LIQT 13D/A, 9 June 2026, https://www.sec.gov/Archives/edgar/data/1307579/000117152026000133/xslSCHEDULE_13D_X02/primary_doc.xml)

The company’s R&D spend is a rounding error at $276k for the quarter, a figure that sits awkwardly against the promotional imagery of ‘innovation projects’ and ‘unique technology for purification of liquids and gases.’ LiqTech’s core claim is its silicon-carbide ceramic membranes, which it says offer superior fouling resistance in high-solids wastewater-useful for oil & gas, power, and chemical customers. Yet the 10-Q shows only $269k spent on capex, hinting that the filters on the shelf are more likely to gather dust than orders. (source: LIQT 10-Q, 31 March 2026; Research & Innovation Projects, https://www.liqtech.com/about-liqtech/innovation/)

If investors want a chart, the best guide is the cash runway: $2.7m in the bank against quarterly burn of nearly $2m implies less than two quarters of cushion. The file has no quarterly revenue disclosure, no EPS, and no guidance-just a balance sheet that looks more like a beta site for a water-boarding exhibit than a going-concern filtration business. Until LiqTech can convert ceramic membranes into recurring revenue faster than it converts cash into inventory, the stock is a bet on narrative, not operations. (source: LIQT 10-Q, 31 March 2026; LIQT SEC submissions JSON, https://data.sec.gov/submissions/CIK0001307579.json)